Accelerating organ
research, Exponentially.
OrganX is a nonprofit health organization (NPHO) established to exponentially accelerate advances in organ technologies and patients' access to organ health. Guided by patients — that is where an NPHO differentiates itself from the private sector.
Modernizing medicine, guided by patients.
Our vision is to modernize medicine by enhancing medical guidelines and public health policies, supporting the world's leading institutions to accelerate their research, and working on early technologies not yet ready for prime time.
Our goals directly align with WHO Digital Health's objectives and the Triple Billion Target — digital health can revolutionize how people worldwide achieve higher standards of health and access services that protect their well-being, accelerating progress toward SDG 3.
Our goal is threefold.
Partner
With governments, IGOs, NGOs, research institutions, medical associations and the private sector to enhance medical guidelines — fostering faster HCP adoption and patient use of new organ technologies.
Support
World-class research institutions that lack proper funding, with donations and loans of equipment, consumables and platforms to accelerate their research.
Work
On bench technologies many stakeholders are unable or unwilling to develop — too risky, too costly, too complex or too early in the R&D continuum — through research partnerships, grants and donations.
Four platforms, one continuum — from bench to patient.
Xsupport
We provide financial and process support to world-leading research institutions by putting latest-generation genomics, transcriptomics and digital equipment and consumables at their disposal.
This accelerates the development of advanced organ technologies, and therefore a faster time to patients.
GlobalX
Our Public-Private-Partnership platform supports countries in the developing world with under-invested healthcare ecosystems — particularly in Africa.
We partner with Healthcare Authorities, Healthcare Organizations and Research Institutions to set up local or pan-country biomedical research platforms, addressing the growing burden of NCDs.
OrganXchange
We established the first blockchain organs exchange in the world supported by clinical institutions.
Operated on a nonprofit basis, it combines blockchain with AI to make transplantation more effective, efficient, transparent and trustworthy — a fully virtualized and tokenized transplant ecosystem.
GeneXpression
We leverage advanced AI combined with transcriptomics and gene expression capabilities to enhance current clinical practice.
These minimally invasive diagnostics detect organ injuries, multiple cancer types, autoimmune diseases and disease progression earlier and more accurately than the standard of care.
At the heart of the global health ecosystem.
OrganX chose to settle in Switzerland for its world-leading position in the combined fields of nonprofit and healthcare. The country sits at the heart of Europe and is part of the Schengen free trade zone.
The EU and Switzerland foster close relations in politics, trade and science, with a long tradition of research partnerships such as Horizon 2020, Euratom, the Fusion Program and healthcare initiatives. Switzerland also ranks 7 of 180 countries on the Transparency International index.
Global health actors based in Switzerland
- World Health Organization
- Red Cross
- Médecins Sans Frontières
- ETH & EPFL
- World Economic Forum
- Banff Foundation for Allograft Pathology
- dHealth Foundation
- Drugs for Neglected Diseases Initiative
- GAVI Alliance
- Global Health Institute
- Global Forum for Health Research
- Biopharmaceutical companies
- And 200+ others…
Partner with OrganX.
Research institutions, healthcare authorities, funders and industry partners — reach out to explore a collaboration.